Correlation Between Lyra Therapeutics and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and SAB Biotherapeutics, you can compare the effects of market volatilities on Lyra Therapeutics and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and SAB Biotherapeutics.
Diversification Opportunities for Lyra Therapeutics and SAB Biotherapeutics
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Lyra and SAB is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and SAB Biotherapeutics
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the SAB Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Lyra Therapeutics is 16.77 times less risky than SAB Biotherapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The SAB Biotherapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 5.40 in SAB Biotherapeutics on August 24, 2024 and sell it today you would earn a total of 1.90 from holding SAB Biotherapeutics or generate 35.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 75.4% |
| Values | Daily Returns |
Lyra Therapeutics vs. SAB Biotherapeutics
Performance |
| Timeline |
| Lyra Therapeutics |
| SAB Biotherapeutics |
Lyra Therapeutics and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and SAB Biotherapeutics
The main advantage of trading using opposite Lyra Therapeutics and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
| SAB Biotherapeutics vs. Lyra Therapeutics | SAB Biotherapeutics vs. Hookipa Pharma | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |